Evidence map›Paper›PMID 35849119›Full record

ArticleJournal of the Pediatric Infectious Diseases Society2022

Clinical Presentation and Severity of Adenovirus Detection Alone vs Adenovirus Co-detection With Other Respiratory Viruses in US Children With Acute Respiratory Illness from 2016 to 2018.

Varvara Probst, Andrew J Spieker, Tess Stopczynski, Laura S Stewart, Zaid Haddadin, Rangaraj Selvarangan, Christopher J Harrison, Jennifer E Schuster, Mary A Staat, Monica McNeal and 13 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of the Pediatric Infectious Diseases Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Observational
  2. Article
  3. Risk factors for severe lower respiratory tract infection among children under 5 years of age hospitalized with respiratory syncytial virus.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 1 country.

Varvara ProbstDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee, USA.
Andrew J SpiekerDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Tess StopczynskiDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Laura S StewartDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee, USA.
Zaid HaddadinDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee, USA.ORCID 0000-0001-6863-6185
Rangaraj SelvaranganDepartment of Pathology and Laboratory Medicine, University of Missouri-Kansas City and Children's Mercy Hospital, Kansas City, Missouri, USA.ORCID 0000-0003-3275-6657
Christopher J HarrisonDepartment of Pathology and Laboratory Medicine, University of Missouri-Kansas City and Children's Mercy Hospital, Kansas City, Missouri, USA.
Jennifer E SchusterDepartment of Pediatrics, University of Missouri-Kansas City and Children's Mercy Kansas City, Kansas City, Missouri, USA.
Mary A StaatDepartment of Pediatrics, College of Medicine, University of Cincinnati and Division of Infectious Diseases, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Monica McNealDepartment of Pediatrics, College of Medicine, University of Cincinnati and Division of Infectious Diseases, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Geoffrey A WeinbergDepartment of Pediatrics, School of Medicine and Dentistry, University of Rochester, Rochester, New York, USA.ORCID 0000-0002-3900-379X
Peter G SzilagyiDepartment of Pediatrics, School of Medicine and Dentistry, University of Rochester, Rochester, New York, USA.
Julie A BoomDepartment of Pediatrics, Baylor College of Medicine, Houston, Texas, Texas Children's Hospital, Houston, Texas, USA.
Leila C SahniDepartment of Pediatrics, Baylor College of Medicine, Houston, Texas, Texas Children's Hospital, Houston, Texas, USA.
Pedro A PiedraDepartment of Pediatrics, Baylor College of Medicine, Houston, Texas, Texas Children's Hospital, Houston, Texas, USA.
Janet A EnglundDepartment of Pediatrics, University of Washington School of Medicine and Seattle Children's Hospital, Seattle, Washington, USA.
Eileen J KleinDepartment of Pediatrics, University of Washington School of Medicine and Seattle Children's Hospital, Seattle, Washington, USA.
Marian G MichaelsDepartment of Pediatrics, School of Medicine, University of Pittsburgh and University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
John V WilliamsDepartment of Pediatrics, School of Medicine, University of Pittsburgh and University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Angela P CampbellDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Manish PatelDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Susan I GerberDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Natasha B HalasaDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee, USA.
Vanderbilt University Medical Center · USBaylor College of Medicine · USCenters for Disease Control and Prevention · USChildren's Mercy Hospital · USChildren's Hospital of Pittsburgh · USCincinnati Children's Hospital Medical Center · USSeattle Children's Hospital · USUniversity of California, Los Angeles · USUniversity of Rochester · US

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
IP21-002, Enhanced Surveillance Network for Enteric and Respiratory Viruses in Children: Assessing Disease Burden, Natural History, and Vaccine EffectivenessU01IP001158 · IP · UNIVERSITY OF ROCHESTER · PI WEINBERG, GEOFFREY ALAN · 2021 to 2025
$10.2M
NCATS NIH HHS UL1 TR000445NCIRD CDC HHS U01 IP001049NCIRD CDC HHS U01 IP001158
6 · The paper itself

Abstract

backgroundHuman adenovirus (HAdV) is commonly associated with acute respiratory illnesses (ARI) in children and is also frequently co-detected with other viral pathogens. We compared clinical presentation and outcomes in young children with HAdV detected alone vs co-detected with other respiratory viruses.

methodsWe used data from a multicenter, prospective, viral surveillance study of children seen in the emergency department and inpatient pediatric settings at seven US sites. Children less than 18 years old with fever and/or respiratory symptoms were enrolled between 12/1/16 and 10/31/18 and tested by molecular methods for HAdV, human rhinovirus/enterovirus (HRV/EV), respiratory syncytial virus (RSV), parainfluenza (PIV, types 1-4), influenza (flu, types A-C), and human metapneumovirus (HMPV). Our primary measure of illness severity was hospitalization; among hospitalized children, secondary severity outcomes included oxygen support and length of stay (LOS).

resultsOf the 18,603 children enrolled, HAdV was detected in 1,136 (6.1%), among whom 646 (56.9%) had co-detection with at least one other respiratory virus. HRV/EV (n = 293, 45.3%) and RSV (n = 123, 19.0%) were the most frequent co-detections. Children with HRV/EV (aOR = 1.61; 95% CI = [1.11-2.34]), RSV (aOR = 4.48; 95% CI = [2.81-7.14]), HMPV (aOR = 3.39; 95% CI = [1.69-6.77]), or ≥ 2 co-detections (aOR = 1.95; 95% CI = [1.14-3.36]) had higher odds of hospitalization compared to children with HAdV alone. Among hospitalized children, HAdV co-detection with RSV or HMPV was each associated with higher odds of oxygen support, while co-detection with PIV or influenza viruses was each associated with higher mean LOS.

conclusionsHAdV co-detection with other respiratory viruses was associated with greater disease severity among children with ARI compared to HAdV detection alone.

Indexed as

Influenza, HumanMetapneumovirusRespiratory Syncytial Virus, HumanRespiratory Tract InfectionsVirusesAcute DiseaseAdenoviridaeAdolescentChildChild, PreschoolHumansInfantOxygenProspective StudiesRhinovirusOxygenacute respiratory illnessadenovirusco-detectionrespiratory viruses

Identifiers

PMID35849119
PMCPMC13396784
OpenAlexW4285799964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.